Patents by Inventor Monique MATHÉ

Monique MATHÉ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DISULFONATE STILBENES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES
    Publication number: 20250177344
    Abstract: Compounds of general formula: wherein R0A and R0B are independently selected from hydrogen and pharmaceutically acceptable cations; and RA and RB are identical and selected from amide, carbamate, sulphonamide, azido, cyano and halide. Also, a pharmaceutical composition including one of the compounds. The composition may also include another active ingredient, especially an antineoplastic agent. Further a compound or a composition for use as a medicament, especially a compound or a composition for use in the treatment of a proliferative disease such as for example cancer.
    Type: Application
    Filed: January 15, 2025
    Publication date: June 5, 2025
    Applicants: UNIVERSITÉ DE NANTES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DU MANS
    Inventors: Fabrice FLEURY, Alexandre DEMEYER, Pierre WEIGEL, Benoit CHENAIS, Monique MATHÉ, Jacques LEBRETON
  • Disulfonate stilbenes for use in the treatment of proliferative diseases
    Patent number: 12233041
    Abstract: Compounds of general formula: wherein R0A and R0B are independently selected from hydrogen and pharmaceutically acceptable cations; and RA and RB are identical and selected from amide, carbamate, sulphonamide, azido, cyano and halide. Also, a pharmaceutical composition including one of the compounds. The composition may also include another active ingredient, especially an antineoplastic agent. Further a compound or a composition for use as a medicament, especially a compound or a composition for use in the treatment of a proliferative disease such as for example cancer.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: February 25, 2025
    Assignees: UNIVERSITÉ DE NANTES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DU MANS
    Inventors: Fabrice Fleury, Alexandre Demeyer, Pierre Weigel, Benoit Chenais, Monique Mathé, Jacques Lebreton
  • DISULFONATE STILBENES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES
    Publication number: 20220016068
    Abstract: Compounds of general formula: wherein R0A and R0B are independently selected from hydrogen and pharmaceutically acceptable cations; and RA and RB are identical and selected from amide, carbamate, sulphonamide, azido, cyano and halide. Also, a pharmaceutical composition including one of the compounds. The composition may also include another active ingredient, especially an antineoplastic agent. Further a compound or a composition for use as a medicament, especially a compound or a composition for use in the treatment of a proliferative disease such as for example cancer.
    Type: Application
    Filed: November 22, 2019
    Publication date: January 20, 2022
    Applicants: UNIVERSITÉ DE NANTES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DU MANS
    Inventors: Fabrice FLEURY, Alexandre DEMEYER, Pierre WEIGEL, Benoit CHENAIS, Monique MATHÉ, Jacques LEBRETON